nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
BRCA genes: lessons learned from experimental and clinical cancer
|
Muggia, F. |
|
|
22 |
S1 |
p. i7-i10 |
artikel |
2 |
Conclusions: fruits of the convergence of laboratory, clinic and public
|
Muggia, F. |
|
|
22 |
S1 |
p. i67-i68 |
artikel |
3 |
Editorial Board
|
|
|
|
22 |
S1 |
p. iii |
artikel |
4 |
Genetic modifiers of cancer risk for BRCA1 and BRCA2 mutation carriers
|
Milne, R.L. |
|
|
22 |
S1 |
p. i11-i17 |
artikel |
5 |
Hereditary breast cancer: clinical features and risk reduction strategies
|
Paradiso, A. |
|
|
22 |
S1 |
p. i31-i36 |
artikel |
6 |
Impact of MRI surveillance and breast cancer detection in young women with BRCA mutations
|
Warner, E. |
|
|
22 |
S1 |
p. i44-i49 |
artikel |
7 |
Innovative technology for cancer risk analysis
|
Tommas, S. |
|
|
22 |
S1 |
p. i37-i43 |
artikel |
8 |
Introduction
|
Paradiso, A. |
|
|
22 |
S1 |
p. i5-i6 |
artikel |
9 |
Old and new concepts in histopathological characterization of familial breast cancer
|
Mangia, A. |
|
|
22 |
S1 |
p. i24-i30 |
artikel |
10 |
Prevention of breast cancer: the case for studying inhibition of IGF-1 actions
|
Smith, J. |
|
|
22 |
S1 |
p. i50-i52 |
artikel |
11 |
Social and ethical implications of BRCA testing
|
Surbone, A. |
|
|
22 |
S1 |
p. i60-i66 |
artikel |
12 |
Table of Contents
|
|
|
|
22 |
S1 |
p. iv |
artikel |
13 |
The clinical development of inhibitors of poly(ADP-ribose) polymerase
|
Calvert, H. |
|
|
22 |
S1 |
p. i53-i59 |
artikel |
14 |
Title Page
|
|
|
|
22 |
S1 |
p. ii |
artikel |
15 |
Unclassified variants in BRCA genes: guidelines for interpretation
|
Radice, P. |
|
|
22 |
S1 |
p. i18-i23 |
artikel |